Next Stop for Fatty Acid Amide Hydrolase Inhibitors, the Clinic?

  • Daniele Piomelli
    Address correspondence to Daniele Piomelli, Ph.D., Department of Anatomy and Neurobiology, 3101 Gillespie Neuroscience Research Facility, University of California, Irvine, CA 92697-4625.
    Department of Anatomy and Neurobiology, University of California, Irvine, California
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Novacek J.
        • Raskin R.
        • Hogan R.
        Why do adolescents use drugs? Age, sex, and user differences.
        J Youth Adolesc. 1991; 20: 475-492
        • Fabre L.F.
        • McLendon D.
        The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety.
        J Clin Pharmacol. 1981; 21: 377S-382S
        • Jetly R.
        • Heber A.
        • Fraser G.
        • Boisvert D.
        The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
        Psychoneuroendocrinology. 2015; 51: 585-588
        • Rabinak C.A.
        • Angstadt M.
        • Sripada C.S.
        • Abelson J.L.
        • Liberzon I.
        • Milad M.R.
        • Phan K.L.
        Cannabinoid facilitation of fear extinction memory recall in humans.
        Neuropharmacology. 2013; 64: 396-402
        • Black N.
        • Stockings E.
        • Campbell G.
        • Tran L.T.
        • Zagic D.
        • Hall W.D.
        • et al.
        Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis.
        Lancet Psychiatry. 2019; 6: 995-1010
        • Patel S.
        • Hill M.N.
        • Cheer J.F.
        • Wotjak C.T.
        • Holmes A.
        The endocannabinoid system as a target for novel anxiolytic drugs.
        Neurosci Biobehav Rev. 2017; 76: 56-66
        • Chiang K.P.
        • Gerber A.L.
        • Sipe J.C.
        • Cravatt B.F.
        Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use.
        Hum Mol Genet. 2004; 13: 2113-2119
        • Minkov M.
        • Bond M.H.
        A genetic component to national differences in happiness.
        Journal of Happiness Studies. 2017; 18: 321-340
        • Spagnolo P.A.
        • Ramchandani V.A.
        • Schwandt M.L.
        • Kwako L.E.
        • George D.T.
        • Mayo L.M.
        • et al.
        FAAH gene variation moderates stress response and symptom severity in patients with posttraumatic stress disorder and comorbid alcohol dependence.
        Alcohol Clin Exp Res. 2016; 40: 2426-2434
        • Mayo L.M.
        • Asratian A.
        • Lindé J.
        • Morena M.
        • Haataja R.
        • Hammar V.
        • et al.
        Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: A randomized, controlled experimental medicine trial.
        Biol Psychiatry. 2020; 87: 538-547

      Linked Article